help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cunningham, M. J.
Right arrow Articles by Steiner, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cunningham, M. J.
Right arrow Articles by Steiner, R. A.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 4 1760-1766
Copyright © 2004 by The Endocrine Society

Galanin-Like Peptide as a Possible Link between Metabolism and Reproduction in the Macaque

Matthew J. Cunningham, Muhammad Shahab, Kevin L. Grove, Jarrad M. Scarlett, Tony M. Plant, Judy L. Cameron, M. Susan Smith, Donald K. Clifton and Robert A. Steiner

Graduate Program in Neurobiology and Behavior (M.J.C.) and Departments of Physiology and Biophysics (M.J.C., R.A.S.) and Obstetrics and Gynecology (J.M.S., D.K.C., R.A.S.), University of Washington, Seattle, Washington 98195; Department of Cell Biology and Physiology, University of Pittsburgh School of Medicine (M.S., T.M.P.), Pittsburgh, Pennsylvania 15261; and Division of Neuroscience, Oregon National Primate Research Center (K.L.G., J.L.C., M.S.S.), Beaverton, Oregon 97006

Address all correspondence and requests for reprints to: Dr. Robert A. Steiner, Department of Physiology and Biophysics, University of Washington, Box 357290, Seattle, Washington 98195-7290. E-mail: steiner{at}u.washington.edu.


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Galanin-like peptide (GALP) is a hypothalamic neuropeptide that has been implicated in the control of feeding, metabolism, and reproduction. The goal of this study was to examine the effects of central infusions of GALP on GnRH and LH secretion and to identify physiological factors that influence the expression of GALP mRNA in the brain of a primate species. Infusions of GALP into the lateral cerebroventricle of the macaque caused a significant increase in LH secretion, which was blocked by administration of the GnRH receptor antagonist acyline. However, the expression of GALP mRNA in the arcuate nucleus, as determined by in situ hybridization, was not regulated by either estradiol or progesterone. Compared with feeding ad libitum, fasting for 48 h produced a significant reduction in the hypothalamic expression of GALP mRNA. GALP neurons were found to express both neuropeptide Y Y1 receptor and serotonin 2C receptor by double-label in situ hybridization. Taken together, these results suggest that GALP neurons play a role of integrating metabolic signals, which are relayed to circuits controlling GnRH release in the macaque.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
SINCE ITS DISCOVERY as an endogenous ligand for galanin receptors, galanin-like peptide (GALP) and its mRNA have been localized to cells of the hypothalamic arcuate nucleus (Arc), median eminence, and neurohypophysis (1, 2, 3, 4, 5, 6). GALP cDNA has been cloned from several mammalian species, including humans and macaques (1, 6, 7, 8). The human GALP gene is located on chromosome 19q13.43 and is comprised of six exons (6). GALP mRNA expression is highly regulated by the adipocyte-derived hormone leptin, being increased by exogenous leptin injection to fasted rats and decreased in several rodent models of insufficient leptin signaling (ob/ob and db/db mice and fa/fa rats) (2, 7, 8). The responsiveness of GALP neurons to leptin is likely to reflect the expression of the long form of the leptin receptor (Ob-Rb) in nearly all GALP neurons (5, 6). The injection of GALP directly into the cerebral ventricles causes changes in food intake and body weight as well as stimulates the release of LH in rodents (9, 10, 11, 12, 13). Little is known about the functional significance of GALP in the primate.

The reproductive system of the macaque, like that in other mammals, is sensitive to changes in energy availability (14, 15). Leptin is believed to be part of the signaling mechanism that leads to this sensitivity; however, the means by which this signal (and others) is transmitted to GnRH neurons are largely unknown (16). The observations that GALP is regulated by leptin and has the ability to stimulate LH secretion have led to the hypothesis that GALP may serve as an intermediary between energy reserves and reproductive neuroendocrine output. The primary focus of these studies was to provide evidence for a similar relationship in the nonhuman primate. To this end, we tested several hypotheses concerning the function of GALP in macaques: 1) that intracranial injections of GALP would elicit LH secretion; 2) that GALP mRNA would be regulated by gonadal steroids; 3) that GALP mRNA would be regulated by fasting; and 4) that GALP neurons would be receptive to signals in the brain (other than leptin) that are known to be involved in regulating food intake.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Experimental animals

All procedures were approved by the institutional animal care and use committees of University of Pittsburgh (experiment 1), Oregon National Primate Research Center (ONPRC; experiments 2 and 3), or University of Washington (experiment 4) and were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.

Reagents

Artificial cerebrospinal fluid (aCSF) was custom-prepared by Life Technologies (Grand Island, NY) as described previously (17). Rat GALP-(1–60) was synthesized as previously described (9) and has 75% amino acid identity with the cloned sequence of macaque GALP (1, 6). GALP was dissolved in aCSF and filtered through a 0.22-µm pore size syringe filter, and 200-µl aliquots containing either 500 or 1428 µg were stored at –20 C. GnRH and acyline were synthesized at The Salk Institute (La Jolla, CA) and Bioqual (Rockville, MD), respectively and were made available by the Contraception and Reproductive Health Branch of Center for Population Research, National Institute of Child Health and Human Development (NICHD). GnRH was diluted in saline, and acyline was dissolved in 5% aqueous mannitol.

Experimental design

Experiment 1: lateral ventricle infusion of GALP. Three adult (62–79 months of age) agonadal male rhesus monkeys (Macaca mulatta) were used in the study. The monkeys were housed in individual cages and maintained under a controlled photoperiod (lights on from 0700–1900 h) and temperature (20 C). Monkeys were fed daily at approximately 1100 h with a high protein monkey diet (no. 5045, PMI Nutrition International, Richmond, IN), supplemented with fruit in the afternoon. Drinking water was available ad libitum.

Surgical procedures were conducted under aseptic conditions after sedation with ketamine hydrochloride [20 mg/kg body weight (BW), im/iv; Vetlar, Parke-Davis, Morris Plains, NJ] and anesthesia with isoflurane inhalation (1.5–2.5% with oxygen). The monkeys were implanted with an indwelling jugular and/or femoral catheter, then fitted with a jacket and tether system for obtaining sequential blood samples (18). Intravenous catheters were kept patent by infusion of heparinized saline (4 U/ml; ~4 ml/h). Monkeys were castrated 2–8 months before initiation of the present experiment for studies of testicular function. Three weeks to 4 months before the start of the present experiment, monkeys were implanted sc with three 4-cm SILASTIC brand [3.35 mm (inside diameter) x 4.65 mm (outside diameter); Dow Corning, Midland, MI] implants filled with crystalline testosterone to suppress LH secretion.

To administer GALP centrally, monkeys were implanted with a 22-gauge stainless steel cannula in the lateral cerebroventricle using an approach similar to that described previously (19). The intracerebroventricular (ICV) catheter was led with the venous catheter through the tether to a swivel device on top of the cage that allowed infusions to be given without sedating the monkeys. The initial dose of GALP (500 µg; ~50 µg/kg BW) was chosen to be comparable to that used previously in similar studies in the rat (10). A 200-µl aliquot of GALP or aCSF (described above) was infused through the ICV catheter (~200 µl/min) between 1030 and 1130 h. Animals received both treatments on separate occasions in a cross-over design. Sequential blood samples (1.5 ml) were obtained from the iv catheter into sterile glass tubes. Blood samples were collected at 20-min intervals for 3 h pre- and postinfusion periods. Immediately thereafter, some monkeys were administered an injection of GnRH (0.3 µg, iv), and a blood sample was collected 10 min later to confirm the responsivity of the gonadotropes. After plasma was harvested, red blood cells were resuspended in heparinized saline and returned to the monkeys. To assess the role of GnRH in mediating any action of GALP on LH release, two monkeys were injected with the GnRH receptor antagonist, acyline (60 µg/kg BW in the morning and 120 µg/kg BW in the evening, sc) under ketamine sedation (50 mg, iv) 1 d before GALP administration (20).

Experiment 2: regulation of GALP mRNA by ovarian steroids. Brain tissue for this experiment was provided by the Nonhuman Primate Reproductive Tissue Bank of NICHD Specialized Cooperative Centers Program in Reproductive Research. Details of the experimental procedure have been reported previously (21). Briefly, adult female rhesus monkeys exhibiting normal menstrual cyclicity were ovariectomized and hysterectomized (spayed) at the ONPRC 3 months before steroid capsule implantation. Spayed rhesus macaques were treated with an empty SILASTIC brand capsule (Spay group; n = 5), with a capsule containing estradiol (E) for 28 d (E group; n = 5), or with an empty capsule for 14 d, then with a capsule containing progesterone (P) for 14 d (P group; n = 5), or treated with a capsule containing E for 28 d and then supplemented with a capsule containing P for the final 14 of the 28 d (EP group; n = 5). At the end of the steroid treatment period, animals were euthanized, and the heads were perfused with 4% paraformaldehyde. All solutions were made with diethylpyrocarbonate-treated water. Brains were removed, postfixed, cryoprotected, then frozen and stored at –80 C until processed for in situ hybridization (ISH).

Experiment 3: regulation of GALP mRNA by fasting. Eight juvenile male Japanese macaques (Macaca fuscata; 1–2 yr old) at ONPRC were housed individually for 2 wk before being killed and were fed two meals a day at 0900 and 1500 h. Macaques were either allowed to feed ad libitum (n = 4) or were fasted for 48 h (n = 4) starting at 1300 h, missing four regularly scheduled meals (1500 and 0900 h for 2 d) before being killed at 1300 h 2 d later. On the afternoon of the second day of fasting, macaques were perfused as previously described (22, 23). The brains were removed, and hypothalamic tissue blocks were cut and immersed in the same fixative for 2 h at 4 C. The tissue blocks were immersed in 10% glycerol solution for 24 h at 4 C, then saturated in 20% glycerol. The tissue was frozen on dry ice and stored at –80 C until processed for ISH.

Experiment 4: GALP mRNA colocalization studies. Three ovariectomized adult female pigtailed macaques (Macaca nemestrina) were obtained through the Tissue Distribution Program at the Washington National Primate Research Center. All animals were sedated with ketamine (10 mg/kg BW, im) and anesthetized with sodium pentobarbital (25 mg/kg BW, iv). Brains were removed from the skull, and a hypothalamic block of tissue was removed, frozen on dry ice, and stored at –80 C until processed for ISH.

RIA

Plasma concentrations of LH for experiment 1 were measured with a double-antibody RIA system that employs recombinant cynomolgus LH (AFP6936) as standard and radioiodinated tracer, and a rabbit polyclonal antiserum to recombinant LH (AFP342994) as first antibody (24). Reagents were provided by the National Hormone and Peptide Program. The sensitivity of the assay varied from 0.05–0.2 ng/ml, and the intra- and interassay coefficients of variation were less than 9% and less than 12%, respectively. Details of ovarian steroid assays performed for experiment 2 have been reported previously (21).

Histology

For experiments with perfused tissue from ONPRC (experiments 2 and 3), sections were cut on a sliding microtome at 25 µm in the coronal plane through the rostral-caudal extent of the Arc and collected in cryoprotectant. A set comprised of every 10th section was washed three times in sodium phosphate buffer made with diethylpyrocarbonate-water, mounted on SuperFrost Plus slides (VWR Scientific, West Chester, PA), allowed to dry completely, and then stored at –80 C. For the experiment with nonperfused tissue (experiment 4), brains were cryostat-sectioned at 20 µm in the coronal plane and thaw-mounted onto SuperFrost Plus slides. Sections were collected into sets of every 10th section through the rostral-caudal extent of the Arc. Slides were then stored at –80 C.

Plasmid information

All of the cDNA constructs that were not provided by others [short/long GALP and neuropeptide Y (NPY) Y1] were synthesized by PCR and cloned into the pAMP1 plasmid by methods previously described (6).

Short and long GALP

Two different GALP cDNA constructs were used as templates for riboprobes for ISH, as described previously (6). The pAMP1 plasmid (Invitrogen, Carlsbad, CA) containing either a 314-bp fragment (short GALP) or a 629-bp fragment (long GALP) of the macaque GALP gene was used for in vitro transcription of antisense riboprobes. The short GALP construct was used for experiment 2, and the long GALP was used for experiments 3 and 4.

NPY Y1 receptor

A 763-bp portion of macaque Y1 cDNA sequence [corresponding to bases 159–921 of rhesus macaque Y1 (25); GenBank accession no. AF303089] was synthesized by PCR and cloned into pAMP1.

Serotonin 2C (5-HT2C) receptor

This plasmid was provided by Dr. Cynthia Bethea, ONPRC, and experiments using this plasmid have been reported previously (26). A fragment containing 294 bp of the macaque 5-HT2C receptor cDNA was cloned by PCR into the pGEM-T plasmid (Promega Corp., Madison, WI) with primers designed to target bases 36–329 of the human ortholog (GenBank accession no. AF498983).

NPY

This probe was provided by Carolyn Worby (University of Michigan, Ann Arbor, MI). A 521-bp fragment of human NPY cDNA was subcloned into Bluescript II KS (Stratagene, La Jolla, CA) as described previously (27).

Riboprobe preparation

Plasmids were linearized by restriction enzyme digest and were purified by phenol/chloroform extraction. Typically, radioactive antisense or sense riboprobe was synthesized in vitro by inclusion of the following ingredients in a volume of 20 µl: 250 µCi [33P]UTP (PerkinElmer Life Sciences, Boston, MA); 1 µg linearized plasmid DNA; 0.5 mM each of ATP, CTP, and GTP; and 40 U of the appropriate RNA polymerase (T7, T3, or SP6 RNA Polymerase Plus, Ambion, Inc., Austin, TX). After 2 h, template DNA was digested with ribonuclease (RNase)-free deoxyribonuclease (Roche, Indianapolis, IN). Riboprobe was separated from unincorporated nucleotides with a NucAway Spin Column (Ambion, Inc.) reconstituted with 10 mM Tris (pH 8.0), 1 mM EDTA, and 100 mM NaCl.

For nonradioactive ISH, antisense riboprobes were synthesized with DIG RNA labeling mix (Roche) and the appropriate RNA polymerase according to the manufacturer’s protocol. After synthesis, the reaction was digested with deoxyribonuclease and purified as described above.

In situ hybridization

Controls. Two types of negative controls were used to demonstrate specificity of the Y1 riboprobe: slides were incubated with either radiolabeled antisense probe in the presence of an excess (>100-fold) of unlabeled antisense probe or an equivalent concentration of radiolabeled sense riboprobe. The specificity of all other probes has been determined previously (6, 26, 27).

Single-label ISH. Tissue from experiments 2 and 3 were subjected to single-label ISH as described previously with slight modifications (6). Slides were removed from –80 C, briefly fixed, and then subjected to proteinase K treatment (10 µg/ml) for 30 min at 37 C. Sections were then acetylated, delipidated, and dehydrated. After this pretreatment, slides were stored at room temperature until used for hybridization. Radiolabeled, antisense GALP riboprobe (short GALP for experiment 2, long GALP for experiment 3) was denatured, dissolved in hybridization solution at a concentration of 0.2 pmol/ml along with transfer RNA (1.9 mg/ml), and applied to slides. Slides were covered with silane-coated glass coverslips, placed in a humid chamber, and incubated overnight at 55 C. The following day, slides were treated with RNase and washed under conditions of increasing stringency. Slides were then dehydrated, air-dried, and dipped in NTB-3 liquid emulsion (Eastman Kodak Co., Rochester, NY). Slides were developed after optimum exposure (several days), and coverslips were applied.

Double-label ISH. Tissue from experiment 4 was subjected to double-label ISH as described previously with slight modifications (6). Slides were processed before hybridization as described above, except proteinase K treatment was omitted. One set of tissue spanning the Arc was used for each of three separate double-label ISH experiments in which GALP mRNA was colocalized with Y1, 5-HT2C, or NPY mRNA. For these experiments, the long GALP construct was used to make digoxigenin-labeled riboprobe, whereas the other probes (Y1, 5-HT2C, and NPY) were radiolabeled. Radiolabeled antisense riboprobe and digoxigenin-labeled riboprobe (concentration determined empirically) were denatured, dissolved in hybridization solution along with transfer RNA (1.7 mg/ml), and applied to slides. Slides were covered with silane-coated glass coverslips, placed in a humid chamber, and incubated overnight at 55 C. The following day, slides were treated with RNase and washed under conditions of increasing stringency. Sections were incubated in blocking buffer and then in Tris buffer containing antidigoxigenin fragments conjugated to alkaline phosphatase (Roche) diluted 1:200 overnight at room temperature. Vector Red (Vector Laboratories, Inc., Burlingame, CA) was used as substrate for alkaline phosphatase according to the manufacturer’s directions. Slides were dipped in 70% ethanol and air-dried. After air-drying, slides were dipped in NTB-3 emulsion. Slides were developed several days later, and coverslips were applied.

Image analysis

Single-label ISH. For determination of GALP mRNA regulation in experiments 2 and 3, slides were analyzed as previously described (28). Custom-designed software was used (by an experimenter who was blind to the treatment groups) to count silver grains from all clusters that were judged to be GALP mRNA-expressing cells in the Arc of all sections processed. Thus, each animal generated data points for the number of grains per cell and the total number of cells. Readings from individual slides were averaged within animals, and these numbers were used as individual n values for analysis of treatment group means.

Double-label ISH. The coexpression of GALP mRNA with various other mRNAs within the same cells was analyzed as previously described (27). GALP mRNA-containing cells were identified under fluorescent illumination, and custom-designed software was used to count the number of silver grains (corresponding to radiolabeled mRNA) over each cell. Signal to background ratios (SBRs) for individual cells were calculated; an individual cell was considered to be double-labeled if it had an SBR of 3 or more. For each animal, the amount of double-labeling was calculated as a percentage of the total number of GALP mRNA-expressing cells and then averaged across animals to produce the mean and SEM.

Statistical analysis

For experiments 2 and 3, group means were compared by ANOVA and t test, respectively. Differences were considered significant at P < 0.05.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Experiment 1: lateral ventricle infusion of GALP

All monkeys showed increased LH secretion in response to infusions of GALP (Fig. 1Go). Monkeys 2692 and 2651 were infused with 500 µg GALP (Fig. 1Go, A and B), whereas monkey 2649 was infused with 1428 µg GALP (Fig. 1CGo). On a separate occasion, monkey 2649 received an infusion of 500 µg GALP (data not shown); however, these data are not presented here due to incomplete suppression of basal LH release by the testosterone implant at the time of that particular infusion trial. Within 40 min of ICV GALP infusion, all three monkeys examined demonstrated a marked rise in LH secretion that peaked by 60 min after infusion and lasted nearly the entire postinfusion sampling period (Fig. 1Go). No evidence of increased LH secretion was observed after aCSF infusion. Two monkeys were pretreated with the GnRH receptor antagonist acyline before receiving GALP infusion. Administration of acyline abolished the effect of GALP infusion on LH secretion in both animals tested (Fig. 1Go, A and B).



View larger version (18K):
[in this window]
[in a new window]
 
FIG. 1. Plasma LH concentration in agonadal male macaques. LH profiles are from three different animals: 2692 (A), 2651 (B), and 2649 (C). Samples were taken every 20 min for 3 h both pre- and postinfusion (infusion = time zero). On separate occasions, either aCSF (•) or GALP (500 µg in A and B; 1428 µg in C; {circ}) was infused into the lateral cerebral ventricle. On another occasion, two of the three macaques (A and B) received GALP infusions 1 d after receiving two sc injections of the GnRH receptor antagonist acyline ({blacktriangleup}). Ten minutes after the end of the postinfusion sampling period, two of the three macaques (A and B) were given a GnRH bolus (0.3 µg, iv; arrow) to confirm the responsiveness of the gonadotropes.

 
Experiment 2: regulation of GALP mRNA by ovarian steroids

The results of hormone assays from these animals have been reported previously (21). The mean serum E concentration for both the E and EP groups is consistent with levels during the mid- to late follicular phases of the menstrual cycle, and the mean serum P concentration for the P and EP groups is consistent with levels during the midluteal phase. No differences in GALP mRNA expression were detected across the four treatment groups, as measured by both grains per cell (Fig. 2AGo) and total number of cells counted (Fig. 2BGo).



View larger version (17K):
[in this window]
[in a new window]
 
FIG. 2. Effects of ovarian steroids on GALP mRNA. Female rhesus macaques were spayed and treated for 28 d with an empty SILASTIC brand capsule (Spay; n = 5) or E (n = 5), were treated for 14 d with an empty capsule before 14 d of treatment with P (n = 5), or were treated with a combination of E for 28 d and P for 14 d (EP; n = 5). GALP mRNA was quantified by recording the number of silver grains per cell (A) and the total number of GALP mRNA-expressing cells counted (B). •, Individual data points from each treatment group. {square}, Mean ± SEM.

 
Experiment 3: regulation of GALP mRNA by fasting

Monkeys who had been fasted 48 h before being killed had significantly fewer grains per cell corresponding to GALP mRNA than ad libitum fed monkeys (76 ± 4 vs. 90 ± 1, respectively; P < 0.05; Fig. 3AGo). However, no difference in the counted number of GALP mRNA-expressing cells was detected between the two treatment groups (Fig. 3BGo).



View larger version (19K):
[in this window]
[in a new window]
 
FIG. 3. Effect of fasting on GALP mRNA. Male Japanese macaques either were allowed to feed ad libitum (n = 4) or were fasted for 48 h (n = 4) before quantification of GALP mRNA, as measured by silver grains per cell (A) and total number of GALP mRNA-expressing cells counted (B). •, Individual data points from each treatment group. {square}, Mean ± SEM. *, P < 0.05 vs. ad libitum-fed group.

 
Experiment 4: GALP mRNA colocalization studies

NPY Y1 receptor. Y1 receptor mRNA was expressed in the Arc, dorsomedial ventromedial nucleus, paraventricular nucleus, bed nucleus of the stria terminalis, and amygdala of the pigtailed macaque. Many cells expressing GALP mRNA had clusters of silver grains (representing the expression of Y1 mRNA) overlying them (Fig. 4Go, A and B). Quantitative analysis of SBR, with a threshold of signal three times greater than background, showed that 42 ± 5% of the GALP mRNA-expressing cells counted also expressed Y1 mRNA.



View larger version (142K):
[in this window]
[in a new window]
 
FIG. 4. Coexpression of GALP mRNA with Y1 mRNA or 5-HT2C mRNA. Representative photomicrographs from the brains of female pigtailed macaques. Fluorescent photomicrographs (A and C) show GALP mRNA-expressing cells filled with Vector Red substrate (arrow). Darkfield photomicrographs show clusters of silver grains representing a Y1 mRNA-expressing cell (B) or a 5-HT2C mRNA-expressing cell (D) overlying a GALP mRNA-expressing cell (arrow). Arrowheads represent silver grain clusters not overlying GALP mRNA-expressing cells. Approximately 42 ± 5% of GALP cells coexpress Y1 mRNA, and 24 ± 3% of GALP cells coexpress 5-HT2C mRNA (n = 3 for each experiment).

 
5-HT2C receptor. The expression pattern seen for 5-HT2C mRNA was similar to that described previously (26), with silver grain clusters formed in the Arc, ventrolateral ventromedial nucleus, lateral septum, preoptic area, and amygdala. Some cells expressing GALP mRNA had clusters of silver grains (representing the expression of 5-HT2C mRNA) overlying them (Fig. 4Go, C and D). Quantitative analysis of SBR, with a threshold of signal three times greater than background, showed that 24 ± 3% of the GALP mRNA-expressing cells counted also expressed 5-HT2C mRNA.

NPY. The expression of NPY mRNA in the Arc of the pigtailed macaque tended to be in the ventromedial portions of the rostral Arc, whereas the expression of GALP mRNA was highest in the dorsomedial Arc. In the caudal Arc, where the majority of GALP mRNA-expressing cells were found, few NPY mRNA expressing cells were observed. Although NPY and GALP mRNA-expressing cells were found in close proximity to one another, extremely low levels of coexpression of the two mRNA species were observed (data not shown). During the analysis of GALP/NPY coexpression, it was noted that several GALP mRNA-expressing cells had a SBR of 3 or more, but this was not attributable to NPY silver grain clusters directly over these cells. In these cases, NPY-associated clusters were adjacent to GALP cells, but the expression of NPY was so great that silver grains from these clusters spilled over onto GALP cells. These cells were excluded from the analysis. Quantitative analysis of SBR, with a threshold of signal three times greater than background, showed that approximately 3% of the GALP mRNA-expressing cells counted also expressed NPY mRNA.


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Infusions of GALP into the brain stimulate LH secretion in rats and mice (9, 10); in this study we have extended this observation to a nonhuman primate species. We have also provided evidence that GALP elicits LH secretion through a GnRH-dependent mechanism, as the ability of GALP to increase LH secretion is blocked by the GnRH receptor antagonist acyline. This is consistent with the previous observation that GALP-stimulated LH release in the rat is blocked by coadministration of a GnRH receptor antagonist (10). Matsumoto et al. (10) also provide evidence that the actions of GALP are distinct from those of galanin in this context, as galanin does not stimulate LH secretion when tested under the same conditions as GALP. Although we did not directly compare the actions of GALP and galanin on LH secretion in this experiment, we have previously found that galanin infused directly into the Arc/median eminence of the male rhesus macaque does not elicit either GnRH or LH release (29). As a note of caution, there is at least some evidence that the location of neuropeptide infusion (ICV vs. intranuclear) can affect the outcome of such experiments (30).

Female rhesus macaques that were spayed had GALP mRNA expression not demonstrably different from that of spayed macaques who received replacement E, P, or both hormones, indicating that the expression of GALP mRNA is not influenced by these ovarian steroids. This also implies that GALP does not play a significant role in the feedback control of gonadotropin secretion by ovarian steroids during the menstrual cycle. We are confident that our treatment regimen was sufficient to detect a difference had one existed, as previous experiments on tissue from the same monkeys found regulation of other mRNA species between steroid treatment groups (21). This result is consistent with our previous finding that GALP mRNA is not regulated by estrogen treatment of ovariectomized rats (28). Notwithstanding, this negative finding does not rule out the possibility that GALP is regulated by steroids in a nontranscriptional manner, or that GALP contributes to the physiological release of GnRH secretion in the intact female macaque.

The expression of GALP mRNA in the Arc of the Japanese macaque is reduced by 48 h of fasting. In the fasted rat, GALP mRNA expression is significantly up-regulated by exogenous leptin injections (2). We did not measure leptin levels in the current experiment, but Lado-Abeal et al. (31) reported that within 24 h of fasting, the serum leptin concentration fell below detectable levels in pubertal male rhesus macaques. Taking into account that the majority of GALP mRNA-expressing cells in pigtailed macaques express leptin receptor mRNA (6), these observations are consistent with the hypothesis that leptin tonically stimulates GALP mRNA expression in the macaque, and that a fasting-induced reduction of leptin receptor signaling at GALP neurons leads to down-regulation of GALP gene expression. It should be noted, however, that many metabolic changes (including changes in glucose, insulin, and cortisol) have been documented in the fasted male rhesus macaque (14), and the design of the current study would not rule out the possible influence of any of these metabolic factors on the regulation of GALP mRNA during fasting.

We found that a portion of GALP mRNA-expressing cells also express mRNA for the Y1 receptor. Of the six known NPY receptor subtypes, the Y1 receptor is among those implicated in mediating the effects of NPY on energy homeostasis (32, 33). NPY signaling through the Y1 receptor has also been implicated in several roles related to reproductive hormone release, notably as a restraint on the reproductive system before pubertal onset (19, 34, 35) and as a contributing mechanism in the fasting-induced suppression of LH secretion (36, 37). Although GALP is a possible downstream effector of the Y1-mediated actions of NPY, a functional relationship between GALP and NPY has yet to be established in the macaque.

We detected a modest number of GALP mRNA-expressing cells that coexpress mRNA for the 5-HT2C receptor. 5-HT’s anorectic properties are believed to be mediated in part by activating proopiomelanocortin (POMC)-expressing neurons in the Arc via the 5-HT2C receptor (38), and mice lacking the 5-HT2C receptor share an obesity phenotype with mice lacking leptin (39). Again, it remains to be seen whether GALP neurons contribute to any of the functions of serotonin attributed to the 5-HT2C receptor.

GALP mRNA was rarely coexpressed with NPY mRNA in the Arc. The current results are consistent with the findings of Takenoya et al. (40), who reported finding no colocalization between GALP and NPY immunoreactivity in the rat. We have also observed that a small number of POMC neurons coexpress GALP mRNA in the macaque (unpublished observations), consistent with the observations of Takenoya et al. in the rat (40). Both NPY and POMC neurons have been shown previously to express Ob-R in the macaque brain (27), and these two cell types are thought to be the major effectors of leptin’s effects on body weight and food intake in the hypothalamus (41). GALP cells appear to represent a largely novel population of cells expressing the Ob-R in the Arc. In fact, GALP cells appear to also be distinct from several other neuropeptide-containing cell groups found in the Arc, such as somatostatin, AGRP, and galanin (5).

In summary, these studies suggest that GALP neurons are positioned to integrate information regarding nutritional status from varied sources and relay that information to the neuroendocrine reproductive axis. We have presented evidence that GALP mRNA is down-regulated by 48 h of fasting in the male Japanese macaque. The down-regulation of GALP mRNA during fasting is consistent with the hypothesis that the primary role of GALP is as an anorexigenic factor in the context of feeding control mechanisms. Although this may be an effect of reduced leptin signaling in the hypothalamus, it may also be attributable in part to fasting-induced changes in NPY and serotonin signaling at GALP neurons, via the Y1 and 5-HT2C receptors, respectively. We have also demonstrated that GALP is capable of eliciting LH release in the male rhesus macaque through a GnRH-dependent mechanism. Although the macaque species employed in the current study (M. mulatta, M. fuscata, and M. nemestrina) are quite similar in size and reproductive biology (42, 43), M. nemestrina is believed to be phylogenetically distinct from the other two Macaca species (44). Therefore, due caution should be used when generalizing individual results to all Macaca species.


    Acknowledgments
 
We thank Dr. Anne Lichtenwalner and Dawit Teklemichael for their contributions to these experiments. Thanks to Amgen, Inc., for providing GALP, and to Dr. Jamie Baumgartner for his assistance with this project. We are also grateful to Dr. Cynthia Bethea for her contribution of tissue from the Nonhuman Primate Reproductive Tissue Bank of the National Institute of Child Health and Human Development (NICHD) Specialized Cooperative Centers Program in Reproductive Research.


    Footnotes
 
This work was supported by the NICHD, National Institutes of Health, through cooperative agreement (U54-HD-012629, U54-HD-18185, and U54-HD-08610) as part of the Specialized Cooperative Centers Program in Reproductive Research as well as by Grants R01-DK-061517, R01-HD-027142, R01-HD-13254, NSF 0110686, P01-DK-055819, P51-RR-000163, and R01-MH-062677.

Abbreviations: aCSF, Artificial cerebrospinal fluid; Arc, arcuate nucleus; BW, body weight; E, estradiol; GALP, galanin-like peptide; 5-HT2C, serotonin 2C; ICV, intracerebroventricular; ISH, in situ hybridization; NPY, neuropeptide Y; P, progesterone; POMC, proopiomelanocortin; RNase, ribonuclease; SBR, signal to background ratio.

Received September 17, 2003.

Accepted January 13, 2004.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Ohtaki T, Kumano S, Ishibashi Y, Ogi K, Matsui H, Harada M, Kitada C, Kurokawa T, Onda H, Fujino M 1999 Isolation and cDNA cloning of a novel galanin-like peptide (GALP) from porcine hypothalamus. J Biol Chem 274:37041–37045[Abstract/Free Full Text]
  2. Juréus A, Cunningham MJ, McClain ME, Clifton DK, Steiner RA 2000 Galanin-like peptide (GALP) is a target for regulation by leptin in the hypothalamus of the rat. Endocrinology 141:2703–2706[Abstract/Free Full Text]
  3. Kerr NCH, Holmes FE, Wynick D 2000 Galanin-like peptide (GALP) is expressed in rat hypothalamus and pituitary, but not in DRG. NeuroReport 11:3909–3913[Medline]
  4. Larm JA, Gundlach AL 2000 Galanin-like peptide (GALP) mRNA expression is restricted to arcuate nucleus of hypothalamus in adult male rat brain. Neuroendocrinology 72:67–71[CrossRef][Medline]
  5. Takatsu Y, Matsumoto H, Ohtaki T, Kumano S, Kitada C, Onda H, Nishimura O, Fujino M 2001 Distribution of galanin-like peptide in the rat brain. Endocrinology 142:1626–1634[Abstract/Free Full Text]
  6. Cunningham MJ, Scarlett JM, Steiner RA 2002 Cloning and distribution of galanin-like peptide mRNA in the hypothalamus and pituitary of the macaque. Endocrinology 143:755–763[Abstract/Free Full Text]
  7. Juréus A, Cunningham MJ, Li D, Johnson LL, Krasnow SM, Teklemichael DN, Clifton DK, Steiner RA 2001 Distribution and regulation of galanin-like peptide (GALP) in the hypothalamus of the mouse. Endocrinology 142:5140–5144[Abstract/Free Full Text]
  8. Kumano S, Matsumoto H, Takatsu Y, Noguchi J, Kitada C, Ohtaki T 2003 Changes in hypothalamic expression levels of galanin-like peptide in rat and mouse models support that it is a leptin-target peptide. Endocrinology 144:2634–2643[Abstract/Free Full Text]
  9. Krasnow SM, Fraley GS, Schuh SM, Baumgartner JW, Clifton DK, Steiner RA 2003 A role for galanin-like peptide in the integration of feeding, body weight regulation, and reproduction in the mouse. Endocrinology 144:813–822[Abstract/Free Full Text]
  10. Matsumoto H, Noguchi J, Takatsu Y, Horikoshi Y, Kumano S, Ohtaki T, Kitada C, Itoh T, Onda H, Nishimura O, Fujino M 2001 Stimulation effect of galanin-like peptide (GALP) on luteinizing hormone-releasing hormone-mediated luteinizing hormone (LH) secretion in male rats. Endocrinology 142:3693–3696[Abstract/Free Full Text]
  11. Matsumoto Y, Watanabe T, Adachi Y, Itoh T, Ohtaki T, Onda H, Kurokawa T, Nishimura O, Fujino M 2002 Galanin-like peptide stimulates food intake in the rat. Neurosci Lett 322:67–69[CrossRef][Medline]
  12. Seth A, Stanley S, Dhillo W, Murphy K, Ghatei M, Bloom S 2003 Effects of galanin-like peptide on food intake and the hypothalamo-pituitary-thyroid axis. Neuroendocrinology 77:125–131[CrossRef][Medline]
  13. Lawrence CB, Baudoin FM-H, Luckman SM 2002 Centrally administered galanin-like peptide modifies food intake in the rat: a comparison with galanin. J Neuroendocrinol 14:853–860[CrossRef][Medline]
  14. Cameron JL 1996 Regulation of reproductive hormone secretion in primates by short-term changes in nutrition. Rev Reprod 1:117–126[Abstract]
  15. Wade GN, Schneider JE, Li H-Y 1996 Control of fertility by metabolic cues. Am J Physiol 270:E1–E19
  16. Cunningham MJ, Clifton DK, Steiner RA 1999 Leptin’s actions on the reproductive axis: perspectives and mechanisms. Biol Reprod 60:216–222[Abstract/Free Full Text]
  17. Gay VL, Mikuma N, Plant TM 1993 Remote and chronic access to the third cerebral ventricle of the unrestrained prepubertal rhesus monkey. Am J Physiol 264:E476–E481
  18. Suter KJ, Pohl CR, Plant TM 1998 The pattern and tempo of the pubertal reaugmentation of open-loop pulsatile gonadotropin-releasing hormone release assessed indirectly in the male rhesus monkey (Macaca mulatta). Endocrinology 139:2774–2783[Abstract/Free Full Text]
  19. Shahab M, Balasubramaniam A, Sahu A, Plant TM 2003 Central nervous system receptors involved in mediating the inhibitory action of neuropeptide Y on luteinizing hormone secretion in the male rhesus monkey (Macaca mulatta). J Neuroendocrinol 15:965–970[CrossRef][Medline]
  20. Ramaswamy S, Marshall GR, Pohl CR, Friedman RL, Plant TM 2003 Inhibitory and stimulatory regulation of testicular inhibin B secretion by luteinizing hormone and follicle-stimulating hormone, respectively, in the rhesus monkey (Macaca mulatta). Endocrinology 144:1175–1185[Abstract/Free Full Text]
  21. Gundlah C, Lu NZ, Bethea CL 2002 Ovarian steroid regulation of monoamine oxidase-A and B mRNAs in the macaque dorsal raphe and hypothalamic nuclei. Psychopharmacology 160:271–282[CrossRef][Medline]
  22. Koegler FH, Grove KL, Schiffmacher A, Smith MS, Cameron JL 2001 Central melanocortin receptors mediate changes in food intake in the rhesus macaque. Endocrinology 142:2586–2592[Abstract/Free Full Text]
  23. Grove KL, Chen P, Koegler FH, Schiffmaker A, Smith MS, Cameron JL 2003 Fasting activates neuropeptide Y neurons in the arcuate nucleus and the paraventricular nucleus in the rhesus macaque. Brain Res Mol Brain Res 113:133–138[Medline]
  24. El Majdoubi M, Ramaswamy S, Sahu A, Plant TM 2000 Effects of orchidectomy on levels of the mRNAs encoding gonadotropin-releasing hormone and other hypothalamic peptides in the adult male rhesus monkey (Macaca mulatta). J Neuroendocrinol 12:167–176[CrossRef][Medline]
  25. Gehlert DR, Yang P, George C, Wang Y, Schober D, Gackenheimer S, Johnson D, Beavers LS, Gadski RA, Baez M 2001 Cloning and characterization of rhesus monkey neuropeptide Y receptor subtypes. Peptides 22:343–350[CrossRef][Medline]
  26. Gundlah C, Pecins-Thompson M, Schutzer WE, Bethea CL 1999 Ovarian steroid effects on serotonin 1A, 2A and 2C receptor mRNA in macaque hypothalamus. Brain Res Mol Brain Res 63:325–339[Medline]
  27. Finn PD, Cunningham MJ, Pau KY, Spies HG, Clifton DK, Steiner RA 1998 The stimulatory effect of leptin on the neuroendocrine reproductive axis of the monkey. Endocrinology 139:4652–4662[Abstract/Free Full Text]
  28. Cunningham MJ, Krasnow SM, Gevers EF, Chen P, Thompson CK, Robinson ICAF, Smith MS, Clifton DK, Steiner RA 2004 Regulation of galanin-like peptide (GALP) gene expression by pituitary hormones and their downstream targets. J Neuroendocrinol 16:10–18[CrossRef][Medline]
  29. Finn PD, Pau K-YF, Spies HG, Cunningham MJ, Clifton DK, Steiner RA 2000 Galanin’s functional significance in the regulation of the neuroendocrine reproductive axis of the monkey. Neuroendocrinology 71:16–26[CrossRef][Medline]
  30. Pau KY, Berria M, Hess DL, Spies HG 1995 Hypothalamic site-dependent effects of neuropeptide Y on gonadotropin-releasing hormone secretion in rhesus macaques. J Neuroendocrinol 7:63–67[CrossRef][Medline]
  31. Lado-Abeal J, Lukyanenko YO, Swamy S, Hermida RC, Hutson JC, Norman RL 1999 Short-term leptin infusion does not affect circulating levels of LH, testosterone or cortisol in food-restricted pubertal male rhesus macaques. Clin Endocrinol (Oxf) 51:41–51[CrossRef][Medline]
  32. Parker E, Van Heek M, Stamford A 2002 Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status. Eur J Pharmacol 440:173–187[CrossRef][Medline]
  33. Larsen PJ, Tang-Christensen M, Stidsen CE, Madsen K, Smith MS, Cameron JL 1999 Activation of central neuropeptide Y Y1 receptors potently stimulates food intake in male rhesus monkeys. J Clin Endocrinol Metab 84:3781–3791[Abstract/Free Full Text]
  34. Pralong FP, Voirol M-J, Giacomini M, Gaillard RC, Grouzmann E 2000 Acceleration of pubertal development following central blockade of the Y1 subtype of neuropeptide Y receptors. Regul Pept 95:47–52[CrossRef][Medline]
  35. El Majdoubi M, Sahu A, Ramaswamy S, Plant TM 2000 Neuropeptide Y: a hypothalamic brake restraining the onset of puberty in primates. Proc Natl Acad Sci USA 97:6179–6184[Abstract/Free Full Text]
  36. Pralong FP, Gonzales C, Voirol M-J, Palmiter RD, Brunner H-R, Gaillard RC, Seydoux J, Pedrazzini T 2002 The neuropeptide Y Y1 receptor regulates leptin-mediated control of energy homeostasis and reproductive functions. FASEB J 16:712–714[Free Full Text]
  37. Hill JW, Levine JE 2003 Abnormal response of the neuropeptide Y-deficient mouse reproductive axis to food deprivation but not lactation. Endocrinology 144:1780–1786[Abstract/Free Full Text]
  38. Heisler LK, Cowley MA, Tecott LH, Fan W, Low MJ, Smart JL, Rubinstein M, Tatro JB, Marcus JN, Holstege H, Lee CE, Cone RD, Elmquist JK 2002 Activation of central melanocortin pathways by fenfluramine. Science 297:609–611[Abstract/Free Full Text]
  39. Heisler LK, Chu H-M, Tecott LH 1998 Epilepsy and obesity in serotonin 5-HT2C receptor mutant mice. Ann NY Acad Sci 861:74–78[CrossRef][Medline]
  40. Takenoya F, Funahashi H, Matsumoto H, Ohtaki T, Katoh S, Kageyama H, Suzuki R, Takeuchi M, Shioda S 2002 Galanin-like peptide is co-localized with {alpha}-melanocyte stimulating hormone but not with neuropeptide Y in the rat brain. Neurosci Lett 331:119–122[CrossRef][Medline]
  41. Porte D, Jr., Baskin DG, Schwartz MW 2002 Leptin and insulin action in the central nervous system. Nutr Rev 60:S20–29
  42. Roonwal ML, Mohnot SM 1977 Primates of south Asia. Cambridge: Harvard University Press
  43. Robinson JA, Goy RW 1986 Steroid hormones and the ovarian cycle. In: Dukelow WR, Erwin J, eds. Comparative primate biology. Vol 3. New York: Liss; 63–91
  44. Hoelzer GA, Melnick DJ 1996 Evolutionary relationships of the macaques. In: Fa JE, Lindburg DG, eds. Evolution and ecology of macaque societies. Cambridge: Cambridge University Press; 3–19



This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. M. Dungan Lemko, D. K. Clifton, R. A. Steiner, and G. S. Fraley
Altered response to metabolic challenges in mice with genetically targeted deletions of galanin-like peptide
Am J Physiol Endocrinol Metab, September 1, 2008; 295(3): E605 - E612.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
B. J Todd, G. S Fraley, A. C Peck, G. J Schwartz, and A. M Etgen
Central Insulin-Like Growth Factor 1 Receptors Play Distinct Roles in the Control of Reproduction, Food Intake, and Body Weight in Female Rats
Biol Reprod, September 1, 2007; 77(3): 492 - 503.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. M. Castellano, V. M. Navarro, R. Fernandez-Fernandez, J. Roa, E. Vigo, R. Pineda, R. A. Steiner, E. Aguilar, L. Pinilla, and M. Tena-Sempere
Effects of galanin-like peptide on luteinizing hormone secretion in the rat: sexually dimorphic responses and enhanced sensitivity at male puberty
Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1281 - E1289.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cunningham, M. J.
Right arrow Articles by Steiner, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cunningham, M. J.
Right arrow Articles by Steiner, R. A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals